Anthors have evaluated postoperative visual outcome and complications on 60 high myopic patients who had underwent extracapsular cataract extraction (ECCE) with or without posterior chamber intraocular lens (PC IOL) implantation, retrospectively. The average axial length of eyeballs of patients underwent only ECCE and ECCE with PC IOL were 30.7 mm and 27.04 mm, respectively. Corrected visual acuity was improved in 56 eyes (91.5%) after cataract sugery. 19 eyes (63.6%) out of 30 aphakia and 11 eyes(36.2%) out of 30 pseudophakia showed better than 20/40 and this difference was statistically significant (p< 0.05). Posterior capsular opacity and cystoid macular edema (CME) were founf in 7 eyes (23.3%) and in 2 eyes (6.6%) of 30 aphakia, while those were in 2 eyes (6.6%) and 1 eye (3.3.%) of 30 pseudophakia, respectively. However, these complications did not decrease a visual acuity and there was no retinal detachment in both aphakia and pseudophakia, with these resuls, it was founf that the clinical results of ECCE with PC IOL was more effective in visual improvement and prevention of posterior capsular opacity than only ECCE for high myopic patients.
Aphakia* ; Cataract Extraction ; Cataract* ; Humans ; Lenses, Intraocular ; Macular Edema ; Myopia* ; Pseudophakia* ; Retinal Detachment ; Retrospective Studies ; Visual Acuity

PURPOSE: This study sought to determine the 1-year clinical effectiveness and safety of a biodegradable, polymer-containing Biolimus A9™-eluting stent (BES) in Korean patients with acute coronary syndrome (ACS). MATERIALS AND METHODS: A total of 1000 ACS patients with 1251 lesions who underwent implantation of BESs at 22 centers in Korea were enrolled between May 2011 and July 2013. We assessed major adverse cardiac events (MACE) defined as the composite of cardiac death, non-fatal myocardial infarction (MI), and clinical-driven target vessel revascularization at 12 months. RESULTS: Patient mean age was 62.6±11.4 years. 72.8% of the patients were male, 28.5% had diabetes, 32.8% had multi-vessel disease (MVD), and 47.9% presented with acute MI (AMI). The mean global registry of acute coronary events risk score of all patients was 103.0±27.6. The number of stents per patient was 1.3±0.6. The incidences of MACE and definite stent thrombosis at 12 months were 3.9% and 0.2%, respectively. On multivariate Cox-regression analysis, age ≥65 years was identified as an independent predictors of 1-year MACE (hazard ratio=2.474; 95% confidence interval=1.202−5.091). Subgroup analyses revealed no significant differences in the incidence of MACE between patients with and without diabetes (4.3% vs. 3.7%, p=0.667), between those who presented with and without AMI (4.4% vs. 3.4%, p=0.403), and between those with and without MVD (4.6% vs. 3.5%, p=0.387). CONCLUSION: Our study demonstrated excellent 1-year clinical outcomes of BES implantation in patients at low-risk for ACS.
Acute Coronary Syndrome/drug therapy ; Aged ; Drug-Eluting Stents/adverse effects ; Female ; Humans ; Incidence ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Multivariate Analysis ; Proportional Hazards Models ; Republic of Korea ; Sirolimus/adverse effects ; Sirolimus/analogs & derivatives ; Sirolimus/therapeutic use ; Time Factors ; Treatment Outcome